Ex vivo gene transfer in the years to come

Pap, Thomas and Gay, Renate E. and Mueller-Ladner, Ulf and Gay, Steffen (2002) Ex vivo gene transfer in the years to come. ARTHRITIS RESEARCH & THERAPY, 4 (1). ISSN 1478-6354, 1478-6362

Full text not available from this repository. (Request a copy)

Abstract

Synovial fibroblasts (SFs) have become a major target for ex vivo gene transfer in rheumatoid arthritis (RA), but efficient transduction of RA-SFs still is a major problem. The low proliferation rate and heterogeneity of RA-SFs, together with their lack of highly specific surface receptors, have hampered a more extensive application of this technique. Improving transduction protocols with conventional viral vectors, therefore, as well as developing novel strategies, such as alternative target cells, and novel delivery systems constitute a major challenge. Recent progress in this field will lead to the achievement of high transgene expression, and will facilitate the use of gene transfer in human trials.

Item Type: Article
Uncontrolled Keywords: ; ex vivo approach; gene therapy; rheumatoid arthritis; viral vector
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin I
Depositing User: Dr. Gernot Deinzer
Date Deposited: 15 Nov 2021 14:13
Last Modified: 15 Nov 2021 14:13
URI: https://pred.uni-regensburg.de/id/eprint/40701

Actions (login required)

View Item View Item